Roivant Sciences
ROIV
34.75
-0.78
-2.20%
Roivant Sciences
US · ROIV
#747 by market cap
Listed 1970
34.75
-0.78
-2.20%
Live - 5344 symbols - heartbeat 267s ago
· 2026-10-08 07:19
Pre-market
34.17
-1.67%
After-hours
35.06
+0.91%
Overnight
34.55
-0.58%
- Market cap
- 25.10B
- P/E (TTM)i
- -73.94
- P/Bi
- 5.93
- EPSi
- -0.54
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on ROIV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.2 percentage points.
Institutional ownership
- Held by institutions
- 78.50% -0.23pp
- Institutions
- 578 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund50.34%
Hedge Fund18.77%
Individual/Insider18.71%
Public Company3.80%
VC/PE Fund2.27%
Private Company1.63%
Government Pension Fund0.72%
Sovereign Wealth Fund0.66%
Family Office/Trust0.15%
Other2.95%
Top holders as of 2026-06-30
Dan Oren
13.59% · 98.17M sh
FMR
11.19% · 80.83M sh
BlackRock
6.68% · 48.24M sh
Morgan Stanley Investment Management Inc.
5.46% · 39.45M sh
Vivek Ramaswamy
3.54% · 25.53M sh
Vanguard Capital Management, LLC
3.46% · 25.02M sh
QVT Financial LP
3.28% · 23.72M sh
Vanguard Portfolio Management, LLC
3.00% · 21.64M sh
State Street Global Advisors
2.46% · 17.80M sh
UBS Asset Management
2.42% · 17.48M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 16 buys · 34 sells
| Name | Role | Stake |
|---|---|---|
| Vivek Ramaswamy | Former Chairperson | 3.54% |
| Daniel Gold | Independent Director | 1.24% |
| Eric Venker | President | 0.19% |
| Frank Torti | Vant Chair | 0.04% |
| Mayukh Sukhatme | President & Chief Investment Officer | 0.04% |
| Matthew Gline | Chief Executive Officer | 0.02% |
| Ilan Oren | Independent Chairperson | 0.02% |
| James Momtazee | Independent Director | 0.01% |
| Rakhi Kumar | Chief Accounting Officer | 0.01% |
| Richard Pulik | Chief Financial Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Melissa Epperly | Independent Director | Derivative Exercise and Sale | -17,750 | $4.46–36.57 |
| 2026-09-29 | Frank Torti | Vant Chair | Other Acquisition | +40,309 | $36.57 |
| 2026-09-29 | Mayukh Sukhatme | President & Chief Investment Officer | Sale to Issuer | -46,879 | $36.57 |
| 2026-09-29 | Matthew Gline | Chief Executive Officer | Sale to Issuer | -76,171 | $36.57 |
| 2026-09-29 | Eric Venker | President | Derivative Exercise and Sale | -200,000 | $3.85–36.62 |
| 2026-09-19 | Richard Pulik | Chief Financial Officer | Sale to Issuer | -2,129 | $39.77 |
| 2026-09-19 | Jennifer Humes | Chief Accounting Officer | Sale to Issuer | -3,880 | $39.77 |
| 2026-09-15 | Meghan FitzGerald | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Meghan FitzGerald | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | Keith Manchester | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Keith Manchester | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | James Momtazee | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | James Momtazee | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | Daniel Gold | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Daniel Gold | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | Melissa Epperly | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Melissa Epperly | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | Ilan Oren | Independent Chairperson | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Ilan Oren | Independent Chairperson | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-14 | Meghan FitzGerald | Independent Director | Automatic Disposition | -5,112 | $39.68–40.45 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:19:47 · For reference only, not investment advice and not tailored to your situation.